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ABSTRACT
To identify the specific biomarkers of exposure of DON in chickens, a toxicokinetic study was performed
via oral or intravenous application of deoxynivalenol (DON). Doses of 0.75 and 2.25 mg DON/kg of body
weight (BW) were administrated intravenously or orally to the chickens. Next, blood samples were
collected at several time points and plasma was obtained. Liquid chromatography–tandem mass-
spectrometry (LC–MS/MS) was used to quantify plasma levels of DON and its metabolite DON-3-
sulphate (DON-3S). A non-compartmental analysis was performed to study the main toxicokinetic
parameters after intravenous or oral application of the toxin. Regarding oral administration, DON
plasma level was below the limit of detection (LOD) of the method (1.5 ng/mL) and DON-3S could not
be identified. After intravenous administration of DON at 0.75 and 2.25 mg DON/kg BW, the
elimination half-life was 57.1 and 47.7 min, respectively, indicating the rapid elimination of DON. The
metabolite DON-3S was found in plasma of broilers exposed to DON intravenously. The absence of
DON in chicken plasma after oral bolus application suggests the low absorption of this mycotoxin.
The presence of DON-3S in plasma indicates that this metabolite could be the appropriate biomarker
of DON exposure in chickens.
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The occurrence of mycotoxins in animal feed presents a threat
for animal health and can result in important economic loss.
Mycotoxin formation subsequent to fungal growth is depen-
dent on several factors which the most important are tempera-
ture and water activity (Filtenborg et al. 1996). Deoxynivalenol
(DON) is a mycotoxin, mainly produced by Fusarium grami-
nearum and Fusarium culmorum that belongs to the trichothe-
cenes family under conditions of high moisture and low
temperature (Bertero et al. 2018). DON is the most commonly
detected mycotoxin in contaminated food and feedstuffs
worldwide (Gruber-Dorninger et al. 2019). Poultry species are
highly exposed to DON mycotoxin. The maximum rec-
ommended level of DON in poultry feed was fixed by the Euro-
pean Union in complete feed at 5 mg/kg whilst in pigs was
fixed at 0.9 mg/kg (European Commission 2006).
In general, poultry species are considered to be tolerant to
DON Fusarium mycotoxin, which could be explained by differ-
ences in toxicokinetic properties. Indeed, the absorption and
distribution of DON by poultry species are limited and its elim-
ination is rapid (Payros et al. 2016). With regard to the metab-
olism, the analysis of suitable metabolites of exposure in blood
plasma using validated analytical methods, upon toxicokinetics
studies, revealed the formation of DON-3-sulphate (DON-3S) as
a metabolite phase II in poultry species (Devreese et al. 2015).
At molecular and cellular levels, DON inhibits protein bio-
synthesis and induces ribotoxic and oxidative stress and
apoptosis (Payros et al. 2016). The toxic effects of DON are man-
ifested by feed intake reduction, alteration of intestinal func-
tions and immunotoxicity in poultry species (Aguzey et al.
2019; Riahi et al. 2020, 2021; Azizi et al. 2021). To more under-
stand the mode of action and to evaluate animal and human
health risks, knowledge of the kinetic parameters of toxins is
essential. The toxicokinetic studies have to be performed to
elucidate the absorption, distribution, metabolism and
excretion (ADME) pathways of the target mycotoxin in the
target species.
The aim of this study was to assess the toxicokinetics of DON
at two concentrations (0.75 and 2.25 mg DON/kg BW), after
intravenous or oral bolus administration, in broilers plasma
and to determine the most suitable metabolite (s) of exposure
of DON.
2. Materials and methods
2.1. Animals and experimental design
A total of 24 one-day-old male Ross 308 broiler chickens were
randomly distributed into 6 cages at 4 chickens per cage for
28 days. The experimental model was according to the one
described by Osselaere et al. (2013) with minor modifications.
The study was approved by the Ethical Committee for Animal
Experimentation of IRTA, and carried out in accordance with
current regulations on the use and handling of experimental
animals (Decree 214/97, Generalitat de Catalunya, Catalonia,
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Spain). Birds were housed at temperatures of 34°C for the first
two days and temperature decreased gradually 3°C per week
until reaching 22°C at 28 d. The applied light programme was
24 h of light per day the first two days, 18 h of light per day
until 7 days, and 14 h of light per day afterwards. Birds were
received water and starter blank feed ad libitum during the
whole trial. The diet was formulated according to the nutrient
requirements for Ross 308 strain broilers and based on maize
and soybean meal (Table 1). The DON and aflatoxin B1 (AFB1)
contents of the feed provided were evaluated by high perform-
ance liquid chromatography (HPLC) method (Table 1). The
determination of other mycotoxins such as: zearalenone
(ZEN), total fumonisins (FBs) and ochratoxin A (OTA) was per-
formed by the Ridascreen® Zearalenon, Ridascreen® Fumonisin
and Ridascreen® Ochratoxin A enzyme-linked-immunosorbent
assay (ELISA) kits (R-Biopharm), following the manufacturer’s
instructions, with detection limits of 1.75, 25 and 2.5 µg/kg
for ZEN, FBs and OTA, respectively.
At d 28, birds were weighed individually. From all animals,
16 birds were used and divided into 4 groups. DON used in
the trial was obtained from Fermentek (Jerusalem, Israel) and
was dissolved in acetonitrile (ACN) (Honeywell, Seelze,
Germany) to obtain 2.5 mg/mL DON as stock solution. Next,
single doses of 0.75 or 2.25 mg DON/kg of BW were intrave-
nously or orally administrated to the chickens (4 birds for
each application and for each dose), taking into account that
the daily feed intake of broilers was 150 g feed/kg BW. The
intravenous injection was applied in the wing vein using a
25G needle (0.5 × 16 mm, Terumo Europe, Leuven, Belgium).
After the toxin administration, blood samples were taken in
heparinized tubes at different time points at (0) pre-adminis-
tration and at 3, 6, 10, 15, 30, 60 and 120 min post-adminis-
tration. Samples were centrifuged at 2851g for 10 min and
plasma was stored at −20°C until further analysis.
2.2. Compounds, standards and solutions
DON analytical standard was supplied by Sigma-Aldrich
Chemie GmbH (Steinheim, Germany). DON standard was dis-
solved in ACN as a stock solution (1 mg/mL), and then
diluted with HPLC-grade ACN to obtain an individual working
standard solution of 5 µg/mL. The stable internal standard (IS)
isotope (13C15-DON) was obtained from Biopure (Bioser, Barce-
lona, Spain) as 1.2 mL of a solution of 25 µg/mL in ACN. An indi-
vidual working standard solution of 5 µg/mL was prepared by
diluting the above stock solution of 13C15-DON with HPLC-
grade ACN and was stored at −15°C.
2.3. Instrumentation, materials and reagents
The separation of the analytes was performed on a Zorbax Plus
C18 (1.8 μm× 2.1 × 100 mm) column from Agilent (San Jose,
CA, USA). Chicken plasma was analysed on a Transcend 600
LC (Thermo Scientific TranscendTM, Thermo Fisher Scientific,
San Jose, CA, USA) coupled to an Orbitrap (ExactiveTM,
Thermo Fisher Scientific, Bremen, Germany) with an electro-
spray ionization (ESI) source (HESI-II, Thermo Fisher Scientific,
San Jose, CA, USA). Ammonium formate was obtained from
Sigma-Aldrich Chemie GmbH (Steinheim, Germany). ACN and
Methanol (MeOH) (HPLC gradient grade) were purchased
from Honeywell (Seelze, Germany).
2.4. Sample preparation for DON and DON-3s
determination in broilers plasma
Preparation of the plasma extract was carried out according to
the method of Broekaert et al. (2014). Briefly, for calibrator
samples, to 250 µL of blank plasma, 10 µL of a 5 µg/mL internal
standard working solution (13C15-DON), 10 µL of a 5 µg/mL of
the standard working solution of DON and ACN was added
up to a volume of 1 mL.
For incurred samples, to 250 μL of chicken plasma, 10 μL of
13C15-DON IS solution (at 5 µg/mL) and 750 μL of ACN were
added. ACN was added to precipitate plasma proteins. The
samples were vortexed for 1 min approximately. Afterwards,
the samples were centrifuged at 8517g for 10 min. The super-
natant (1 mL) was transferred to a new tube and was evaporated
to dryness under nitrogen flow over a heating block and
Table 1. The formulation and the proximate analysis of the blank control feed.
Ingredients (%) Starter: blank control diet 1–28 days
Maize 54.00




































Notes: DON: deoxynivalenol; ZEN: zearalenone; FBs: fumonisins; OTA: ochratoxin;
AFB1: aflatoxin B1; limit of detection of DON, ZEN, FBs, OTA, and AFB1: 50, 1.75,
25, 0.5 and 0.3 µg/kg, respectively.
aVitamin premix provided following nutrients per kg of diet: vitamin A: 13,500 IU;
vitamin D3: 4800 IU: vitamin E: 67 IU; vitamin B1: 3 mg; vitamin B2: 9 mg;
vitamin B6: 4.5 mg; vitamin B12: 16.5 µg; vitamin K3, 3 mg; calcium pantothe-
nate: 16.5 mg; nicotinic acid, 51 mg; folic acid: 1.8 mg, biotin: 30 µg; Fe: 54 mg;
I: 1.2 mg; Co: 0.6 mg; Cu: 12 mg; Mn: 90 mg; Zn: 66 mg; Se: 0.18 mg; Mo:
1.2 mg.
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reconstituted in 1 mL of ammonium formate 5 mM/MeOH
(50:50, v/v) solution, and 10 μL were injected for (HPLC–MS/
MS) analysis.
2.5. LC–MS/MS analysis
Gradient elution was established with a mobile phase consist-
ing of 5 mM ammonium formate in water (eluent A) and
methanol (eluent B) at a flow rate of 0.2 mL/min. The gradient
elution started at 95% B at 1 min and it was decreased to 0% B
at 8–12 min afterwards it increased to 95% at 12.5 min and
maintained up to 14 min. The column temperature was set at
25°C and the injection volume was 10 µL. MS analyses were
performed using selected reaction monitoring (SRM) mode
with positive and negative electrospray ionization (ESI±). The
settings on the spectrometer were as follows: compounds
were ionized by electrospray ionization in the positive and
negative mode and measured first in full scan and then in tar-
geted MS/MS mode at a collision energy of 30 eV (both in the
range from m/z 50-500). ESI parameters were as follows: spray
voltage, 4 kV; sheath gas (N2, >95%), 35 (adimensional); auxili-
ary gas (N2, >95%), 10 (adimensional); skimmer voltage, 18 V;
capillary voltage, 35 V; tube lens voltage, 95 V; heater tempera-
ture, 305°C; capillary temperature, 300°C. The capillary and
nozzle voltages were 4000 and 95 V ( −95 V in ESI-), respect-
ively. Finally, the data were processed using XcaliburTM
version 3.0 (Quanbrowser and Qualbrowser) and Mass Fron-
tierTM 7.0. The retention time and MS/MS parameters are indi-
cated in (Table 2).
2.6. Toxicokinetic analysis and data evaluation
The toxicokinetic parameters were analysed using non-com-
partmental analysis. The area under the concentration–time
curve from time zero to the last time point (AUC0–t), the
area under the concentration–time curve from time zero to
infinity (AUC0–∞), maximum plasma concentration (Cmax);
elimination rate constant (kel), the half-life of elimination (T1/
2el), the volume of distribution (Vd) and clearance (Cl) were
determined.
3. Results
After a single oral bolus of DON at 0.75 and 2.25 mg/kg BW, no
plasma above the LOQ could be observed for DON and its
metabolite DON-3S. Plasmatic DON concentration vs time
profiles after intravenous injection of DON at both doses
(0.75 and 2.25 mg/kg BW) are shown in Figure 1. Moreover,
from 2 h p.a. no levels above LOQ could be detected for DON
(Figure 1).
The HPLC–MS/MS coupled with orbitrap analysis revealed
the presence of DON-3S in plasma (Figure 2). Since no commer-
cial standard solution of DON-3S is available, accurate quanti-
tative analysis cannot be performed, and the results were
evaluated using the absolute chromatographic peak areas.
Average chromatographic peak areas were calculated per treat-
ment and per time (Figure 2).
The toxicokinetic analysis of both metabolites was per-
formed based only in data obtained after intravenous adminis-
tration (Table 3). The study of the main toxicokinetic
parameters revealed that the AUC0–t and AUC0–∞ after IV
Table 2. HPLC–MS/MS parameters.
Analyte
Retention
time (min) characteristic ion (m/z)
Fragment
ion (m/z)
DONa 8.12 341.1242 [M + CH3COO]
– 201.0747
DON-3Sb 5.80 375.0744 [M-H]– 345.0640




Figure 2. Peak area of deoxynivalenol-3-sulphate (DON-3S) at different times
after intravenous (IV) administration of 0.75 (n = 5) and 2.25 mg DON/kg (n =
4) BW to broiler chickens.
Table 3. Toxicokinetic parameters of DON and DON-3S after intravenous injection





Toxicokinetic parameters of DONb
(AUC0–t) (ng min/mL) 3726 5838
(AUC0–∞) (ng min/mL) 4550 6755
C0 (ng/mL) 66.4 199
Cmax (ng/mL) 75.2 199
kel (1/min) 0.012 0.014
T1/2 el (min) 57.1 47.7
Vd (L/kg) 13.1 22.7
Cl (L/min kg) 0.16 0.33
Toxicokinetic parameters of DON-3Sc
(AUC0–t) (peak area × min) 754,444 1,110,110
(AUC0–∞) (peak area × min) 754,444 1,111,082
C0 (ng/mL) (peak area) 1,097,515 1,403,403
aDON: deoxynivalenol.
bAUC0-t: area under the concentration-time curve from time zero to the last time
point; AUC0-∞: area under the concentration-time curve from time zero to
infinity, Cmax: maximum plasma concentration; kel: elimination rate constant;
T1/2el: half-life of elimination Vd: volume of distribution; Cl: clearance.
cDON-3S: deoxynivalenol 3- sulphate.
Figure 1. Plasma concentration–time profile of DON after a single intravenous
administration of DON of 0.75 (n = 5) and 2.25 mg DON/kg (n = 4) BW to
broiler chickens.
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administration at 2.25 mg/kg BW were much higher than after
IV administration at 2.25 mg/kg BW, which correlates with the
doses administered (Table 3). The toxin clearance from
plasma of broilers intravenously exposed to DON (0.75 or
2.25 mg/kg BW) is rapid (0.16 or 0.33 L/min kg). Furthermore,
DON showed a remarkably shorter elimination half-life
(T½elimination of 57.1 or 47.7 min) after intravenous injection for
both doses.
4. Discussion
To understand the sensitivity of broiler chickens to the toxic
effects of DON, knowledge of the toxicokinetic properties is
necessary. Toxicokinetics deals with what the body does with
a DON mycotoxin when given a relatively high dose
(2.25 mg/kg BW) relative to the guidance dose (0.75 mg/kg
BW). The absorption, distribution, metabolism and elimination
termed ADME processes are involved in toxicokinetics.
No detection of DON mycotoxin and its metabolite phase II
DON-3S in plasma of birds received the toxin orally even at a
high level (2.25 mg/kg BW), presumably due to the low oral
bioavailability of this mycotoxin in broilers (Osselaere et al.
2013). Prelusky et al. (1986) found low levels of radioactivity
in plasma (less than 1% of the dose administrated), when,
orally administered 2.2 mg/bird/day of radiolabelled DON
(14C), to White Leghorn hens by crop intubation. The absolute
oral bioavailability of DON mycotoxin was found to be low
and accounts to only 19.3% in broiler chickens, 20.9% in
Turkeys and 30.4% in pigeons (Osselaere et al. 2013; Devreese
et al. 2015; Antonissen et al. 2016). Furthermore, Broekaert
et al. (2014) showed that the absorbed fraction of DON in
broiler chickens, after oral DON administration (0.5 mg/kg
BW) was only 10.6%, however, in pigs, the absorbed fractions
were 100% for DON, which may explain the difference of sus-
ceptibility to DON mycotoxicosis between these two species.
The concentration of DON in plasma was under LODs for the
applied LC–MS/MS method when broilers fed naturally or
artificially contaminated diet up to 5 mg DON/kg diet for 21
or 35 d (Dänicke et al. 2007; Awad et al. 2011; Osselaere
et al. 2012).
Lun et al. (1988) reported that DON disappeared from the
gastrointestinal tract between the crop and the jejunum, and
no DON was detected in the blood from the portal vein or
heart of laying domestic chickens after intubation with feed
containing contaminated corn.
It has been reported that DON has been widely and transi-
ently distributed into different tissues of broiler chickens
(plasma, muscle, abdominal fat, stomach, large and small intes-
tine, liver, kidney, heart, lung, skin, spleen, brain, testes, ovary
and adrenals) after using oral administration of radio-labelled
DON for five days (Wan et al. 2014). In the current study, the
low Vd may imply the transient distribution of DON in broiler
chickens. The transient distribution may be related to the
rapid elimination of DON (Wan et al. 2014).
In regard to the metabolization of DON in broiler chickens,
the biotransformation of DON on DON-3 S has been shown
in the current study. Devreese et al. (2015) revealed that after
using high-resolution mass spectrometry (HR-MS) analysis of
plasma of turkeys and broiler chickens, DON-3S was the
major metabolite after oral gavage, as well as after intravenous
injection of 0.75 mg/kg BW of DON. In the same way, after a
semi-quantitative analysis using HR-MS, it has been seen that
DON is metabolized to DON-3S in pigeons after intravenous
or oral bolus administration of the parent mycotoxin (Antonis-
sen et al. 2016). After a single intra-crop bolus administration of
0.5 mg/kg body weight DON to broiler chickens aged 21 d and
weighed 1 kg, DON-3S was detected and no DON was found
(Lauwers et al. 2019). The maximum peak of the area of DON-
3S was achieved in plasma after 30 min post administration
(Lauwers et al. 2019). According to the recent study of Jurisic
et al. (2019), after feeding a dose of 3.8 and 7.5 mg DON /kg
of DON feed to laying hens, the analysis of DON in plasma
and eggs by LC–MS/MS revealed that DON-3S is the main
metabolite, with an average concentration of 6.8 and 10 ng/
mL in plasma. Furthermore, the other metabolites, DOM-1,
DON-3α-glucuronide, DON-10-sulfonate and DOM-1-10-sulfo-
nate, were only detected at traces or were not detectable in
chickens and Turkey poults (Devreese et al. 2015; Schwartz-
Zimmermann et al. 2015).
DON-3S was also detected in excreta after chronic feeding of
both levels. Wan et al. (2014) indicated that after the adminis-
tration of radioactive DON, DON-3S was accounting about
88.6% in excreta of broiler chickens. DON is extensively metab-
olized to DON-3S in excreta. The conversion of DON to DON-3S
could occur in the enterocytes of the intestinal epithelium, in
liver and kidney, as hypothesized by Schwartz-Zimmermann
et al. 2015. These authors found that DON-3S is the major
metabolite in excreta of broiler chickens and its biological
recovery accounted 80%. Lauwers et al. (2019) found that the
maximum peak of area of DON-3S was achieved in dried
excreta after 3–6 h post administration.
DON-3S was reported to be a suitable biomarker of DON
exposure in broilers. Sulphation was considered as a detoxifica-
tion pathway (Yi et al. 2006). Then, this pathway of biotrans-
formation may explain the low susceptibility of broilers to
DON toxicity (Wan et al. 2014).
Next to the extensive metabolization on DON-3S, DON is
rapidly eliminated in broiler chickens. The results of rapid
clearance and short elimination of DON found in the current
study were comparable with a previous report in which they
found a total body clearance of 0.12 L/min kg and an elimin-
ation half-life of 27.9 min after intravenous administration of
0.75 mg/kg BW DON to broiler chickens (Osselaere et al.
2013). Similarly, clearance of DON was 0.11 L/min and
T1/2elimination was 18.6 min in broiler chickens exposed to the
DON mycotoxin at 0.5 mg/kg BW intravenously (Broekaert
et al. 2017). This is again comparable to turkeys with a clear-
ance of 0.13 L/min and is rapidly eliminated (T1/2elimination =
37.2 min) upon intravenous DON injection at 0.75 mg/kg BW
(Devreese et al. 2015). Likewise, the toxicokinetic study of
DON in pigeon revealed that upon intravenous administration
of 0.3 mg/kg BW, the total body clearance was 0.20 L/min kg
and the elimination half-life was 20.4 min (Antonissen et al.
2016). The rapid elimination is probably linked with the
polarity of DON and the lower volume of distribution. The
rapid clearance and elimination might be the reason that
poultry are less sensitive to DON compared with other
species (Antonissen et al. 2016).
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5. Conclusions
In conclusion, from the results of this research, it could be
confirmed the low absorption, the limited accumulation and
the rapid clearance and excretion of DON in broilers. DON
was metabolized in DON-3S and this latter phase II metabolite
can be considered the suitable biomarker of DON exposure in
broiler chickens. The characteristics of ADME process of DON
in broiler chickens imply the tolerance of this specie to the
toxic effects of this mycotoxin.
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